Donald R Sullivan1,2,3, Linda Ganzini2,4, Jodi A Lapidus5, Lissi Hansen6, Patricia A Carney7, Molly L Osborne1,8, Erik K Fromme8,9, Seiko Izumi6, Christopher G Slatore1,2,3,10. 1. Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Oregon. 2. Health Services Research and Development, Veterans Affairs Portland Health Care System, Portland, Oregon. 3. Cancer Prevention and Control Program, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. 4. Division of Geriatric Psychiatry, Department of Psychiatry, Oregon Health and Science University, Portland, Oregon. 5. Biostatistics, School of Public Health, Oregon Health and Science University, Portland, Oregon. 6. School of Nursing, Oregon Health and Science University, Portland, Oregon. 7. Department of Family Medicine, Oregon Health and Science University, Portland, Oregon. 8. Palliative Care Service, Oregon Health and Science University, Portland, Oregon. 9. Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. 10. Section of Pulmonary and Critical Care Medicine, Veterans Affairs Portland Health Care System, Portland, Oregon.
Abstract
BACKGROUND: Hospice, a patient-centered care system for those with limited life expectancy, is important for enhancing quality of life and is understudied in integrated health care systems. METHODS: This was a retrospective cohort study of 21,860 decedents with advanced-stage lung cancer diagnosed from January 2007 to June 2013 in the national US Veterans Affairs Health Care System. Trends over time, geographic regional variability, and patient and tumor characteristics associated with hospice use and the timing of enrollment were examined. Multivariable logistic regression and Cox proportional hazards modeling were used. RESULTS: From 2007 to 2013, 70.3% of decedents with advanced-stage lung cancer were enrolled in hospice. Among patients in hospice, 52.9% were enrolled in the last month of life, and 14.7% were enrolled in the last 3 days of life. Hospice enrollment increased (adjusted odds ratio [AOR], 1.07; P < .001), whereas the mean time from the cancer diagnosis to hospice enrollment decreased by 65 days (relative decrease, 32%; adjusted hazard ratio, 1.04; P < .001). Relative decreases in late hospice enrollment were observed in the last month (7%; AOR, 0.98; P = .04) and last 3 days of life (26%; AOR, 0.95; P < .001). The Southeast region of the United States had both the highest rate of hospice enrollment and the lowest rate of late enrollment. Patient sociodemographic and lung cancer characteristics were associated with hospice enrollment. CONCLUSIONS: Among patients with advanced-stage lung cancer in the Veterans Affairs Health Care System, overall and earlier hospice enrollment increased over time. Considerable regional variability in hospice enrollment and the persistence of late enrollment suggests opportunities for improvement in end-of-life care. Cancer 2018;124:426-33.
BACKGROUND: Hospice, a patient-centered care system for those with limited life expectancy, is important for enhancing quality of life and is understudied in integrated health care systems. METHODS: This was a retrospective cohort study of 21,860 decedents with advanced-stage lung cancer diagnosed from January 2007 to June 2013 in the national US Veterans Affairs Health Care System. Trends over time, geographic regional variability, and patient and tumor characteristics associated with hospice use and the timing of enrollment were examined. Multivariable logistic regression and Cox proportional hazards modeling were used. RESULTS: From 2007 to 2013, 70.3% of decedents with advanced-stage lung cancer were enrolled in hospice. Among patients in hospice, 52.9% were enrolled in the last month of life, and 14.7% were enrolled in the last 3 days of life. Hospice enrollment increased (adjusted odds ratio [AOR], 1.07; P < .001), whereas the mean time from the cancer diagnosis to hospice enrollment decreased by 65 days (relative decrease, 32%; adjusted hazard ratio, 1.04; P < .001). Relative decreases in late hospice enrollment were observed in the last month (7%; AOR, 0.98; P = .04) and last 3 days of life (26%; AOR, 0.95; P < .001). The Southeast region of the United States had both the highest rate of hospice enrollment and the lowest rate of late enrollment. Patient sociodemographic and lung cancer characteristics were associated with hospice enrollment. CONCLUSIONS: Among patients with advanced-stage lung cancer in the Veterans Affairs Health Care System, overall and earlier hospice enrollment increased over time. Considerable regional variability in hospice enrollment and the persistence of late enrollment suggests opportunities for improvement in end-of-life care. Cancer 2018;124:426-33.
Authors: Leah L Zullig; George L Jackson; Raye Anne Dorn; Dawn T Provenzale; Rebecca McNeil; Catherine M Thomas; Michael J Kelley Journal: Mil Med Date: 2012-06 Impact factor: 1.437
Authors: Mireille Jacobson; A James O'Malley; Craig C Earle; Juliana Pakes; Peter Gaccione; Joseph P Newhouse Journal: Health Aff (Millwood) Date: 2006 Mar-Apr Impact factor: 6.301
Authors: Akiko M Saito; Mary Beth Landrum; Bridget A Neville; John Z Ayanian; Jane C Weeks; Craig C Earle Journal: J Palliat Med Date: 2011-07-18 Impact factor: 2.947
Authors: Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag Journal: N Engl J Med Date: 2012-10-25 Impact factor: 91.245
Authors: Melissa W Wachterman; Corey Pilver; Dawn Smith; Mary Ersek; Stuart R Lipsitz; Nancy L Keating Journal: JAMA Intern Med Date: 2016-08-01 Impact factor: 21.873
Authors: David J Casarett; Jessica M Fishman; Hien L Lu; Peter J O'Dwyer; Frances K Barg; Mary D Naylor; David A Asch Journal: J Clin Oncol Date: 2008-12-29 Impact factor: 44.544
Authors: Shi-Yi Wang; Melissa D Aldridge; Cary P Gross; Maureen Canavan; Emily Cherlin; Rosemary Johnson-Hurzeler; Elizabeth Bradley Journal: Med Care Date: 2016-07 Impact factor: 2.983
Authors: Donald R Sullivan; Christopher W Forsberg; Sara E Golden; Linda Ganzini; Steven K Dobscha; Christopher G Slatore Journal: Ann Am Thorac Soc Date: 2018-11
Authors: Austin Lammers; Christopher G Slatore; Erik K Fromme; Kelly C Vranas; Donald R Sullivan Journal: J Thorac Oncol Date: 2018-10-15 Impact factor: 15.609
Authors: Young-Taek Park; Daekyun Kim; Su-Jin Koh; Yeon Sook Kim; Sang Mi Kim Journal: Int J Environ Res Public Health Date: 2022-01-29 Impact factor: 3.390
Authors: Shannon M Nugent; Christopher G Slatore; Linda Ganzini; Sara E Golden; Dana Zive; Kelly C Vranas; Donald R Sullivan Journal: Am J Hosp Palliat Care Date: 2019-01-30 Impact factor: 2.500